|
Correlation between time to PSA progression (TTPP), radiographic progression-free survival (rPFS) and overall survival (OS) in first-line abiraterone/enzalutamide (Abi/Enza) and docetaxel (Doc) treated patients in a prospective cohort study. |
|
|
Consulting or Advisory Role - Bayer Holding; Janssen; Sanofi/Aventis |
Speakers' Bureau - Astellas Oncology; Bayer Health; Janssen; Sanofi/Aventis |
Travel, Accommodations, Expenses - Astellas Oncology; Celgene; Janssen; Sanofi/Aventis |
|
|
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Janssen-Cilag |
Consulting or Advisory Role - Bayer; Bayer (I); Janssen; Janssen (I) |
Research Funding - AstraZeneca (Inst); Bayer (Inst); Janssen (Inst) |
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Janssen; Roche |
|
|
Speakers' Bureau - Janssen-Cilag; Roche |
Travel, Accommodations, Expenses - Janssen-Cilag; Roche |
|
|
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Bristol-Myers Squibb; Clovis Oncology; Eisai; EUSA Pharma; Ipsen; Janssen-Cilag; Merck Sharp & Dohme; Pfizer; Roche; Sanofi |
Speakers' Bureau - Celgene; Kiowa; Lilly; Novartis; Pierre Fabre |
Research Funding - Astellas Pharma; Pfizer |
Travel, Accommodations, Expenses - Janssen-Cilag; Pfizer; Roche |
|
|
Honoraria - Astellas Pharma; Bayer; Janssen-Cilag; Pfizer; PharmaMar; Roche; Sanofi |
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Janssen-Cilag (Inst); Sanofi (Inst) |
Travel, Accommodations, Expenses - Janssen-Cilag; Pfizer; Roche |
|
|
Consulting or Advisory Role - MSD, Sanofi, Astra Zeneca |
Speakers' Bureau - Asofarma; MSD Oncology |
Travel, Accommodations, Expenses - MSD, Sanofi, Astra Zeneca, Astellas, J&J, Bayer |
|
|
Honoraria - Astellas Medivation; AstraZeneca; Bristol-Myers Squibb; Janssen-Cilag; MSD; Pfizer; Roche; Sanofi |
Consulting or Advisory Role - Astellas Medivation; Bayer; Bristol-Myers Squibb; Janssen-Cilag; MSD; Pfizer; Roche |
Research Funding - MSD (Inst); Pfizer (Inst); Takeda (Inst) |
Travel, Accommodations, Expenses - Astellas Medivation; Bayer; Bristol-Myers Squibb; Clovis Oncology; Ipsen; Janssen; Novartis |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
|
Travel, Accommodations, Expenses - Bristol-Myers Squibb |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Ipsen; Janssen-Cilag; Pfizer; Roche; Sanofi; Takeda |
Travel, Accommodations, Expenses - Pfizer |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Clovis Oncology; Janssen Oncology; Merck Sharp & Dohme; Roche/Genentech; VCN Biosciences |
Research Funding - AstraZeneca/MedImmune; Bristol-Myers Squibb; Incyte; Janssen Oncology; Merck Sharp & Dohme; Pfizer/EMD Serono |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Janssen Oncology; Roche |
|
|
Honoraria - Bayer; Janssen; Sanofi |
Consulting or Advisory Role - AstraZeneca; Bayer; Clovis Oncology; Janssen |
Research Funding - Astellas Medivation (Inst); AstraZeneca (Inst); Bayer (Inst); Genentech/Roche (Inst); Janssen (Inst); Pfizer (Inst); Tokai Pharmaceuticals (Inst) |
Travel, Accommodations, Expenses - Bayer; Ipsen; Janssen |